Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Net Cash Flow: 2019-2024

Historic Net Cash Flow for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to -$252.6 million.

  • Maravai Lifesciences Holdings' Net Cash Flow fell 627.98% to -$26.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$334.5 million, marking a year-over-year decrease of 23003.38%. This contributed to the annual value of -$252.6 million for FY2024, which is 341.73% down from last year.
  • According to the latest figures from FY2024, Maravai Lifesciences Holdings' Net Cash Flow is -$252.6 million, which was down 341.73% from -$57.2 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Net Cash Flow registered a high of $315.2 million during FY2021, and its lowest value of -$252.6 million during FY2024.
  • For the 3-year period, Maravai Lifesciences Holdings' Net Cash Flow averaged around -$76.3 million, with its median value being -$57.2 million (2023).
  • Its Net Cash Flow has fluctuated over the past 5 years, first spiked by 7,452.39% in 2020, then tumbled by 341.73% in 2024.
  • Yearly analysis of 5 years shows Maravai Lifesciences Holdings' Net Cash Flow stood at $211.5 million in 2020, then surged by 49.04% to $315.2 million in 2021, then plummeted by 74.34% to $80.9 million in 2022, then crashed by 170.70% to -$57.2 million in 2023, then slumped by 341.73% to -$252.6 million in 2024.